SCHEMBL10073469

SCHEMBL10073469

CCc1ccc2c(c1)sc1c3ccccc3sc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 7/20 0.42
RAB9A P51151 6/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 8/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
LMNA P02545 4/20 0.40
NPC1 O15118 3/20 0.40
GLA P06280 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
GPR3 P46089 1/20 0.40
POLB P06746 2/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10031393 0.91 NPC1 (0.46) KIF11L3MBTL1ATMALDH1A1RAB9A
SCHEMBL12436066 0.89 GPR3 (0.54) KIF11L3MBTL1ATMALDH1A1RAB9A
SCHEMBL1687688 0.87 NPC1 (0.43) KIF11L3MBTL1ATMALDH1A1RAB9A
SCHEMBL20635997 0.83 LIMK1 (0.46) KIF11L3MBTL1RAB9ASMN1; SMN2HPGD
SCHEMBL6860677 0.83 ALDH1A1 (0.50) KIF11L3MBTL1ALDH1A1RAB9AKDM4E
SCHEMBL17037073 0.82 ALDH1A1 (0.42) L3MBTL1ATMALDH1A1RAB9AKDM4E
SCHEMBL16978711 0.82 RAB9A (0.44) KIF11L3MBTL1ATMALDH1A1RAB9A
SCHEMBL429352 0.81 GPR3 (0.43) ALDH1A1KDM4ELMNAGPR3TP53
SCHEMBL17040006 0.81 GPR3 (0.43) ALDH1A1KDM4ELMNAGPR3TP53
SCHEMBL10072886 0.81 GPR3 (0.43) ALDH1A1KDM4ELMNAGPR3TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767327-B2 Compound, pattern forming substrate, coupling agent, and pattern formation method NIKON CORPORATION (JP) 2023-09-26 US disclosed
US-10937964-B2 Organic semiconductor material TOKYO INSTITUTE OF TECHNOLOGY (JP) 2021-03-02 US disclosed
EP-3428987-B1 ORGANIC SEMICONDUCTOR MATERIAL TOKYO INST TECH (JP) 2020-02-26 EP disclosed
EP-3428987-A1 ORGANIC SEMICONDUCTOR MATERIAL Tokyo Institute of Technology (JP) 2019-01-16 EP disclosed
US-20180351106-A1 ORGANIC SEMICONDUCTOR MATERIAL TOKYO INSTITUTE OF TECHNOLOGY (JP) 2018-12-06 US disclosed
EP-2685514-B1 ORGANIC SEMICONDUCTOR MATERIAL TOKYO INST TECH (JP) 2018-10-03 EP disclosed
US-10056557-B2 Organic semiconductor material TOKYO INSTITUTE OF TECHNOLOGY (JP) 2018-08-21 US disclosed
US-20140081028-A1 ORGANIC SEMICONDUCTOR MATERIAL DIC CORPORATION 2014-03-20 US disclosed
EP-2685514-A1 ORGANIC SEMICONDUCTOR MATERIAL DIC Corporation (JP) 2014-01-15 EP disclosed
US-20130146858-A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b][1]-BENZOTHIOPHENES Heraeuss Precious Metals Metals GmbH & Co., KG (DE) 2013-06-13 US disclosed
US-20130146858-A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b][1]-BENZOTHIOPHENES Heraeuss Precious Metals Metals GmbH & Co., KG (DE) 2013-06-13 US disclosed
US-20130146858-A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b][1]-BENZOTHIOPHENES Heraeuss Precious Metals Metals GmbH & Co., KG (DE) 2013-06-13 US disclosed
WO-2012010292-A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b] [1]-BENZOTHIOPHENES HERAEUS CLEVIOS GMBH (DE) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767327-B2 Compound, pattern forming substrate, coupling agent, and pattern formation method FEM1B, MUS81, MNS1 KIF11 777/4885L3MBTL1 4762/4885ATM 3509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.